Most Recent
The operator of the Royal Perth Hospital has brought legal action against Griffith Hack alleging the law firm contributed to the "dishonest and fraudulent design" of a leading researcher to transfer the intellectual property rights to a stem cell manufacturing method developed inhouse.
Eco-conscious Australian skincare company Sukin has been hit with a lawsuit alleging it misled consumers by selling products labelled with a carbon neutral certification it did not hold.
Titan DMS, which provides software to car dealers across Australia, has expanded cross claims in a legal dispute with leading competitor Pentana Solutions, alleging the rival engaged in misuse of market power by threatening dealers who want to switch providers.
Novartis and and generic drug maker Pharmacor have resolved litigation over the Swiss pharmaceutical giant's patents for blockbuster MS drug Gilenya.
The High Court will not wade into the global debate over whether artificial intelligence inventions should receive patent protection, letting stand a Full Court judgment that overturned a landmark victory for AI pioneer Dr Stephen Thaler.
Media company The Economist has failed in its opposition to registration of a trade mark for The Beer Economist, with an IP Australia delegate saying the mark was not substantially identical or deceptively similar to the UK publisher's brand.
Infant formula maker Care A2 Plus has launched an attack on A2 Milk, filing a lawsuit arguing the dairy giant's trade marks should be cancelled because they're too generic and are being used to sell products that don't exclusively contain the a2 protein.
The maker of Finish dishwashing products has appealed a judgment that removed two of its trade marks for non-use and rejected its claim that a competitor's logo was deceptively similar.
Boutique firm Marquette IP has reached a settlement with a former trade mark attorney who claimed she was sacked for making complaints of bullying by a supervisor.